Crossmark

Assessment of inflammatory and glycemic markers for in-hospital mortality in STEMI patients

Published Online: 2026-01-14

Published Print: 2026-04

Authors

Aygun, Ali https://orcid.org/0000-0002-5190-1445
Saribas, Mehmet Seyfettin https://orcid.org/0000-0002-2037-0522
Tomakin, Mesut https://orcid.org/0000-0002-7767-2177
Koksal, Adem https://orcid.org/0000-0001-8451-7397
Akkaya, Fatih https://orcid.org/0000-0002-9016-4986
Caltekin, Ibrahim https://orcid.org/0000-0002-3973-0655
Toprak, Mustafa https://orcid.org/0009-0001-4930-2144
License Information

Text and Data Mining valid from 2026-01-14

Version of Record valid from 2026-01-14
More Information

Article History

Received: 29 November 2025

Accepted: 22 December 2025

First Online: 14 January 2026

Declarations

:

: This study was conducted in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Declaration of Helsinki and its subsequent amendments or comparable ethical guidelines. Ethical approval was obtained from the Clinical Research Ethics Committee of Ordu University (Approval No: 2025/107; Date: 21.03.2025).

: The authors declare that they have no competing interests.

Document is current